MIRM
4:01 PM
Catalyst Calendar
Thu, Jun 11, 2026
1 updatesThu, Jun 4, 2026
1 updatesSat, May 30, 2026
1 updatesThu, May 21, 2026
1 updatesThu, May 14, 2026
1 updatesMIRM
4:01 PM
Tue, May 12, 2026
3 updatesWed, May 6, 2026
1 updatesMon, May 4, 2026
1 updatesMIRM
8:00 AM
Sun, May 3, 2026
1 updatesMIRM
5:00 PM
Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis on May 4, 2026
Results CallCall Mon, May 4, 2026mirumpharma.com
Wed, Apr 29, 2026
1 updatesMon, Apr 27, 2026
1 updatesMIRM
8:00 AM
Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus
Trial Results • Phase 2mirumpharma.com